Literature DB >> 200353

Inhibition of concanavalin A stimulation of feline lymphocytes by inactivated feline leukemia virus.

L C Hebebrand, L E Mathes, R G Olsen.   

Abstract

In a lymphocyte blast transformation assay, the response of feline lymphocytes to concanavalin A was suppressed 20 to 65 percent in the presence of inactivated feline leukemia virus. The decrease was not due to viral cytotoxicity, as determined by trypan blue viability counts, nor was the virus binding the concanavalin A and interfering with its mitogenic stimulation. The virus may be biochemically repressive in itself, interfering with cell-mediated immunity within the feline system.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 200353

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

Review 1.  Feline leukemia virus: current status of the feline induced immune depression and immunoprevention.

Authors:  R G Olsen; M G Lewis; L J Lafrado; L E Mathes; K Haffer; R Sharpee
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 2.  Mechanisms of virus-induced immune suppression.

Authors:  M A Wainberg; E L Mills
Journal:  Can Med Assoc J       Date:  1985-06-01       Impact factor: 8.262

3.  Nucleotide sequences of a feline leukemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses.

Authors:  M A Stewart; M Warnock; A Wheeler; N Wilkie; J I Mullins; D E Onions; J C Neil
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

4.  Suppressive effect on polyclonal B-cell activation of a synthetic peptide homologous to a transmembrane component of oncogenic retroviruses.

Authors:  M Mitani; G J Cianciolo; R Snyderman; M Yasuda; R A Good; N K Day
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

5.  Antigenic modification: its relation to protective host resistance in murine salmonellosis.

Authors:  N J Bigley; R A Smith; P Warren; W T Minahan; D P Kreps
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

6.  Reversible interference with TCGF activity by virus particles.

Authors:  M A Wainberg; S Vydelingum; M Boushira; J Legacé-Simard; R G Margolese; B Spira; J Mendelson
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

7.  Viral abrogation of lymphocyte mitogenesis: induction of a soluble factor inhibitory to cellular proliferation.

Authors:  E Israel; B Beiss; M A Wainberg
Journal:  Immunology       Date:  1980-05       Impact factor: 7.397

8.  Animal model of human disease: leukemic lymphoma.

Authors:  R G Olsen; L E Mathes; L C Hebebrand; E A Hoover; W S Nichols
Journal:  Am J Pathol       Date:  1980-03       Impact factor: 4.307

9.  Suppression of human lymphocyte mitogen response by retroviruses of type D. I. Action of highly purified intact and disrupted virus.

Authors:  J Denner; V Wunderlich; G Sydow
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

10.  Inhibition by human T-lymphotropic virus (HTLV-I) of T-lymphocyte mitogenesis: failure of exogenous T-cell growth factor to restore responsiveness to lectin.

Authors:  M A Wainberg; B Spira; M Boushira; R G Margolese
Journal:  Immunology       Date:  1985-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.